NCT04584788View on ClinicalTrials.gov

Validation of the O3 Regional Somatic Tissue Oxygenation Monitor

NACompletedINTERVENTIONAL

Enrollment

37

Participants

Timeline

Start Date

November 30, 2020

Primary Completion Date

June 2, 2021

Study Completion Date

June 2, 2021

Conditions

Oxygen Deficiency

Interventions

DEVICE

Masimo O3 Regional Oximeter

Study sensors will be placed on somatic tissues. Readings will be taken from the tissues underneath the O3 sensors.

Trial Locations (1)

Unknown

Site 1, Groningen

Sponsors

Lead Sponsor

Masimo Corporation

All Listed Sponsors

collaborator

University Medical Center Groningen

OTHER

lead

Masimo Corporation

INDUSTRY